When Covering and Discovering Are at Odds: How the Logic of US Health Insurance Undercuts the Promise and Equity of Precision Medicine for People with Hereditary Cancer Risks.

Abstract excerpt

CONTEXT: Despite precision medicine's promise to revolutionize health care, access remains uneven, and disparities persist. This study examines how conflicts between the institutional logics of genetic science ("discovering") and market-based health insurance ("covering") impede precision-driven health equity. METHODS: The authors conducted 44 semistructured in-depth interviews with individuals at elevated risk...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Testing
• Share to Health Services Accessibility